Selectivity of μ-opioid receptor determined by interfacial residues near third extracellular loop

被引:41
作者
Bonner, G [1 ]
Meng, F [1 ]
Akil, H [1 ]
机构
[1] Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA
关键词
opioid receptor; ligand selectivity; mutagenesis; S-35]GTP gamma S;
D O I
10.1016/S0014-2999(00)00578-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We hypothesized that the selectivity profile of the rat mu-opioid receptor for opioid receptor-selective ligands is determined by the nature of the amino acid residues at highly divergent sites in the ligand-binding pocket. To determine which characteristics of these residues contribute to opioid receptor ligand selectivity, we made various mutant receptors that replaced the Lys(303) and Trp(315) residues near the extracellular interface of transmembrane domains VI and VII, respectively. Ligand binding determinations using transiently transfected monkey kidney epithelial (COS-1) cells show that Lys(303) mutations cause little change in the receptor binding profile, whereas the Trp(318) mutant receptors have considerably lower affinity for mu-opioid receptor-selective ligands and greatly increased affinity for delta-opioid receptor-selective ligands. The nature of these mutations show that this effect is not due to sterics or charge alone. [S-35]guanosine-5'-O-(3-thio)-triphosphate ([S-35]GTP gamma S) activity assays show that these residues may influence functional, as well as binding selection. We conclude that a primary role for Trp(318) is to form a basis for ligand selectivity. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 21 条
  • [1] Ballesteros J.A., 1995, Methods in Neurosciences, V25, P366, DOI [DOI 10.1016/S1043-9471(05)80049-7, 10.1016/S1043-9471(05)80049-7]
  • [2] [S-35]GTP gamma S binding: A tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells
    Befort, K
    Tabbara, L
    Kieffer, BL
    [J]. NEUROCHEMICAL RESEARCH, 1996, 21 (11) : 1301 - 1307
  • [3] MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE
    BUNZOW, JR
    SAEZ, C
    MORTRUD, M
    BOUVIER, C
    WILLIAMS, JT
    LOW, M
    GRANDY, DK
    [J]. FEBS LETTERS, 1994, 347 (2-3) : 284 - 288
  • [4] CHEN C, 1987, MOL CELL BIOL, V7, P745
  • [5] SITE-DIRECTED MUTAGENESIS OF VIRTUALLY ANY PLASMID BY ELIMINATING A UNIQUE SITE
    DENG, WP
    NICKOLOFF, JA
    [J]. ANALYTICAL BIOCHEMISTRY, 1992, 200 (01) : 81 - 88
  • [6] Emmerson PJ, 1996, J PHARMACOL EXP THER, V278, P1121
  • [7] Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
    Gether, U
    [J]. ENDOCRINE REVIEWS, 2000, 21 (01) : 90 - 113
  • [8] GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265
  • [9] HJORTH SA, 1995, MOL PHARMACOL, V47, P1089
  • [10] REGULATION OF THE HUMAN ENKEPHALIN PROMOTER BY 2 ISOFORMS OF THE CATALYTIC SUBUNIT OF CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-DEPENDENT PROTEIN-KINASE
    HUGGENVIK, JI
    COLLARD, MW
    STOFKO, RE
    SEASHOLTZ, AF
    UHLER, MD
    [J]. MOLECULAR ENDOCRINOLOGY, 1991, 5 (07) : 921 - 930